Noninvasive markers of liver fibrosis in Latin America and Mexico

Annals of Hepatology

Volumn 9, Issue SUPPL. 1, 2010, Pages 43-48

  Uribe, Misael ^a,b   Gutiérrez Grobe, Ylse ^a   Kobashi Margáin, Ramón Arturo ^a   Méndez Sánchez, Nahum ^a  

^a LIVER RESEARCH UNIT   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE MARKER; ECHOGRAPHY; ELASTOGRAPHY; EQUIPMENT DESIGN; EVALUATION RESEARCH; HEPATITIS C; HEPATOGRAPHY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER SIZE; MEXICO; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PUNCH BIOPSY; SOUTH AND CENTRAL AMERICA; THROMBOCYTE COUNT; TISSUE SLICE; BIOPSY; BLOOD; HOSPITALIZATION; LIVER CIRRHOSIS; MASS SCREENING; METHODOLOGY; PATHOLOGY; PREDICTIVE VALUE; VIROLOGY;

BIOLOGICAL MARKERS; BIOPSY; ELASTICITY IMAGING TECHNIQUES; HEPATITIS C, CHRONIC; HUMANS; LATIN AMERICA; LIVER CIRRHOSIS; MASS SCREENING; MEXICO; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 79952113944     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31723-5     Document Type: Article

References (25)

1. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1991; 23(3): 437-455
2. Liang JJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med 2000; 132(4): 296-305.
3. Poynard T. Should we have the courage to say not to systematic liver biopsy? Gastroenterol Clin Biol 2003; 27: 844-846.
4. Calés P, Boursier J, Chaigneau J, Obert F, Rousselet MC. Treatment of liver fibrosis: clinical aspects. Gastroenterol Clin Biol 2009; 33 (10-11): 958-966.
5. Harbin WP, Robert NJ, Ferrucci JTJ. Diagnosis of cirrhosis based on regional changes in hepatic morphology a radiological and pathological analysis. Radiology 1980; 135(2): 273-283.
6. Lewin M, Poujol RA, Boelle PY, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007; 46(3): 658-665.
7. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19(6): 513-520.
8. Gaiani S, Gramantieru L, Venturoli N, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997; 27(6): 979-985.
9. Aube C, Oberti F, Korali N, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999; 30(3): 472-478.
10. Samonakis DN, Cholongitas E, Thalheimer U, et al. Hepatic Venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrosis. Liver transpl 2007; 13(9): 1305-1311.
11. Moal F, Chappard D, Wang J, et al. Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Hepatology 2002; 36(4): 840-849.
12. Leroy V. Other non invasive markers of liver fibrosis. Gastroenterol Clin Biol 2008; 32(6) 52-57.
13. Parkes J, Guha IM, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C J. Hepatol 2006; 44(3): 462-474.
14. Poynard T, Aubert A, Bedossa P et al. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991, 100: 1397-1402.
15. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Juou T, Murawaki Y. Fibroindex a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007; 45(2): 297-306.
16. Sterling RK, Lissen E, Clumeck N. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV (HCV co-infection). Hepatology 2006; 43(6): 1317-1325.
17. Vallet-Pichard A, Mallet V, Nalpas B, et al. An inexpensive and accurate marker fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007; 47(1): 32-36.
18. Pinzani M. Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched. Gut 2006; 55(3): 310-312.
19. Bedosa P, Carrat F. Liver fibrosis: screening is not staging. J. Hepatol 2009; 50(6):1268-1269.
20. Friedrich RM, Ong MF, Marstens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134(4): 960-974.
21. Bravo AA, Sheth SG, Chopra S. Liver Biopsy. N Engl J Med 2001; 344(7): 495-500.
22. Fourcher J, Chanteloupe E, Verginiol J, et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut 2006; 55: 403-408.
23. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41(1): 48-54.
24. Carrión JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006; 12: 1791-1798.
25. Poynard T, Munteanu M, Imbert-Bismut F, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004; 50(8): 1344-1355.